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Pathogenic organisms are frequently attenuated after long-term culture in vitro. The mechanisms of the attenuation
process are not clear, but probably involve mutations of functions required for replication and pathogenicity in vivo. To
identify these functions, a direct comparison must be made between attenuated genomes and those that remain pathogenic
in vivo. In this study, we used the heterochimeric SCID-hu Thy/Liv mouse as an in vivo model to define human immunodefi-
ciency virus type 1 (HIV-1) determinants which are uniquely required for replication in vivo. The Lai/IIIB isolate and its
associated infectious molecular clones (e.g., HXB2) were found to infect T cell lines but failed to replicate in the SCID-hu
Thy/Liv model. When a lab worker was accidentally infected by Lai/IIIB, however, HIV-1 was isolated only from infection of
primary PBMC, and not from infection of T cell lines. We hypothesized that the lab worker was exposed to a heterogeneous
viral stock which had been attenuated by passage in immortalized T cell lines. Either a rare family member from this stock
was selected for in vivo replication or, alternatively, an attenuated genotype dominant in vitro may have reverted to become
more infectious in vivo. To address this hypothesis, we have used the SCID-hu Thy/Liv model to study the replication of
HXB2 and of HXB2 recombinant viruses with HIV-1 fragments isolated from the infected lab worker. HXB2 showed no or
very low levels of replication in the Thy/Liv organ. Replacement of its subgenomic fragment encoding the envelope gene
with a corresponding fragment from the lab worker isolate generated a recombinant virus (HXB2/LW) which replicated
actively in SCID-hu mice. The NEF mutation in the HXB2 genome is still present in HXB2/LW. Thus, the LW sequences encode
HIV-1 determinants which enhance HIV replication in vivo in a NEF-independent mechanism. The specific determinants have
been mapped to the V1–V3 regions of the HIV-1 genome. Six unique mutations in the V3 loop region of HXB2/LW have
been identified which contribute to the increased replication in vivo. q 1997 Academic Press
INTRODUCTION IIIB stock was prepared by infecting the human T leuke-
mia cell line, H9, with infected M2T0/B cell supernatant.
HIV-1 can infect diverse cell types in vivo, including
Subsequent analyses of HIV-1 genome from Lai/IIIB iso-
CD4/ T cells, macrophages, dendritic cells, Langerhans
lates showed that multiple changes have accumulated
cells, and hematopoietic progenitor cells (Fauci, 1993;
during their expansion in vitro (Shaw et al., 1984). For
Levy, 1993; McCune, 1991; Weiss, 1993). HIV-1 isolates
example, the HXB2 genome cloned from Lai/IIIB carries
used in most studies have been expanded and main-
mutations which lead to premature termination of threetained in immortalized human T cell lines. Since the re-
of the nine ORFs (vpr, vpu, and nef). Many other subtleverse transcription process is associated with a high
mutations may have also accumulated. These mutationsintrinsic error rate, it is predictable that the different se-
do not usually affect HIV-1 replication in vitro under thelective pressures in vitro may lead to the generation of
specific culture conditions. Some of them may actuallyvariants with uncertain relationship to isolates which pre-
enhance their replication in certain cell lines. For in-dominate in vivo. Indeed, many lab-adapted isolates of
stance, infection of T cells in vitro often leads to selectionHIV-1 show defects in gene functions such as vpr, vpu,
of HIV-1 mutants carrying mutations in the vpr gene be-and nef (Shaw et al., 1984).
cause vpr causes cell cycle arrest in the infected cellsA particularly instructive example of such adaptation
(Jowett et al., 1995; Rogel et al., 1995). However, due toin vitro may be found in the passage history of HTLV-IIIB
lack of relevant in vivo models, it is not clear which muta-(Lai/IIIB; Chang et al., 1993). Initially derived from human
tions may contribute to HIV replication and pathogenesispatient blood sample and cultured in M2T0/B cells, Lai/
in vivo.
Comparison of ‘‘attenuated’’ HIV-1 isolates with
1 To whom correspondence and reprint requests should be ad-
‘‘pathogenic’’ ones in vitro and in vivo will help to iden-dressed at the Lineberger Comprehensive Cancer Center, School of
tify important viral determinants for replication andMedicine, University of North Carolina, Chapel Hill, NC 27599-7295.
Fax: (919) 966-3015; E-mail: lsu@med.unc.edu. pathogenesis in vivo. Two human/murine chimeric
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models have been established as in vivo models for To address this hypothesis, we have used the SCID-
hu Thy/Liv model to study the replication of HXB2 andstudying HIV-1 replication and pathogenesis. Human
peripheral blood leukocyte (PBL) cells or human fetal of HXB2 recombinant viruses with HIV-1 fragments
isolated from the infected lab worker (Kong et al.,tissues implanted in the C.B17 scid/scid mouse (hu-
PBL-SCID or SCID-hu Thy/Liv, respectively) have been 1989). HXB2 showed no or very low levels of replica-
tion in the Thy/Liv organ. Replacement of its subgeno-successfully used to study HIV-1 replication and CD4/
T cell killing in vivo (McCune et al., 1991; Mosier et mic fragment encoding the envelope ORF with a corre-
sponding fragment from the LW87-1 isolate generatedal., 1989). Important, some unexpected, findings have
been documented from these studies. For example, a recombinant virus (HXB2/LW) which replicated ac-
tively in SCID-hu mice or in the thymus organ cultureit has been shown in the hu-PBL-SCID model that a
macrophage-tropic HIV-1 isolate, which is noncyto- (TOC) model (Bonyhadi et al., 1995). The specific de-
terminants have been mapped to the V1 – V3 regionspathic in vitro, is more potent in killing the CD4/ T
cells engrafted in the SCID mouse than the T-tropic of the HIV-1 genome. Six unique mutations in the V3
loop region have been identified which contribute to(cytopathic in vitro) HIV-1 isolate (Mosier et al., 1993).
However, the human PBLs engrafted in SCID mice are its increased replication in vivo.
physiologically abnormal due to severe xenoactivation
(hyperactivated and anergic) and lack of human RESULTS
lymphoid organs (Huppes et al., 1992; Murphy et al.,
Lab-adapted HIV-1 isolates acquired ability to
1992; Tary-Lehmann and Saxon, 1992).
replicate in the SCID-hu Thy/Liv mouse after
The SCID-hu Thy/Liv model transplants human fetal
passages in vivo
liver and thymus fragments into SCID mice (McCune
et al., 1991, 1988). The Thy/Liv organ developed in the The HIV-1 clone HXB2, like its parental isolate Lai/
IIIB, replicates poorly in the Thy/Liv organ (Bonyhadimouse is tolerized to the host and supports long-term,
normal T cell development (Krowka et al., 1991; Nami- et al., 1995; Fig. 1C). HIV-1 isolated from the lab worker
infected with IIIB/Lai showed altered tropism (Kongkawa et al., 1990). Studies of HIV-1 infection in this
model have shown that HIV-1 viruses isolated from et al., 1989; Weiss et al., 1988). To characterize the
mutations accumulated during in vivo replication, alate-stage AIDS patients replicate efficiently and lead
to thymus depletion, whereas HIV-1 viruses isolated recombinant viral genome (HXB2/LW) was generated
between the molecular clone HXB2 and a 2.7-kb (SalI –from the same patients before AIDS development rep-
licated poorly and did not cause severe thymus dele- BamHI) HIV-1 genomic fragment (LW87-1; Reitz et al.,
1994) obtained by short-term culture of phytohemag-tion (Kaneshima et al., 1994). As shown in the SIV/
monkey model system, the HIV-1 nef function is also glutinin-activated peripheral blood mononuclear cells
(PHA-PBMC) of the infected lab worker (Fig. 1A). Thisrequired for efficient replication and pathogenesis in
the SCID-hu Thy/Liv model (Jamieson et al., 1994). DNA fragment contains HIV-1 3*-half sequences en-
coding tat, rev, vpu, and the majority of env.Analyses of HIV-1 recombinants bearing mutations in
the accessory genes have indicated that the vif and Both HXB2 and HXB2/LW replicated efficiently in
PHA-PBMCs when p24 antigen levels and TCID50 werevpu functions may also be required for this process
(Aldrovandi and Zack, 1996). These HIV-1 recombi- measured (Fig. 1B). HXB2 or HXB2/LW viral superna-
tants were injected intrathymically (about 200 TCID50nants, except the vif mutant, appeared to replicate to
similar levels in PBMC. Thus, the SCID-hu Thy/Liv units/graft). HIV-1 replication was assessed in the
SCID-hu Thy/Liv implant by DNA PCR analysis andmouse is a relevant model to study HIV-1 replication
in a human lymphoid organ. p24 antigen ELISA. No significant HXB2 replication
was detected until late time postinoculation (8 weeksThe Lai/IIIB isolate and its associated infectious
molecular clones (e.g., HXB2) were found to infect T p.i.). In contrast, challenge with the recombinant
HXB2/LW virus was associated with high levels of viralcell lines such as H9 and to be cytopathic in vitro
(Hahn et al., 1984; Popovic et al., 1984). When a lab replication at early time points (3 – 6 weeks postinocu-
lation). Quantitation of proviral DNA confirmed thatworker was accidentally infected by Lai/IIIB, however,
HIV-1 was isolated only from infection of primary about 10% of human thymocytes were infected by
HXB2/LW (Fig. 1D), comparable to the infection levelsPBMC, but not from infection of T cell lines (Kong et
al., 1989; Weiss et al., 1988). We hypothesized that the of NL4.3 or primary isolates (Su et al., 1995). Thymo-
cytes from HXB2-inoculated human thymus graftslab worker was exposed to a heterogeneous viral
stock which had been attenuated by passage in im- (HB-a and HB-b; Fig. 1D) showed no sign of HIV-1
replication. The HIV gag band in lane 2 of HB-a wasmortalized T cell lines. Either a rare family member
from this stock was selected for in vivo replication or, due to contamination, as reanalysis of the same sam-
ple showed no HIV-specific PCR product. The humanalternatively, an attenuated genotype dominant in vitro
may have reverted to become more infectious in vivo. b-globin product was included as a qualitative control
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FIG. 1. (A) History of HXB2 and LW87.1, and construction of HXB2/LW. HIV-1 viral DNA sequences (SalI–BamHI, 5786–8466 in LW87-1, 23) from
the infected lab worker were cloned to replace the SalI–BamHI fragment in HXB2. The resultant proviral DNA (HXB2/LW) was transfected into PHA-
PBMC to generate HIV-1 viral stocks. (B) HXB2 and HXB2/LW replication in PHA-PBMC. The replication of HXB2 and HXB2/LW was compared after
transfection of proviral DNA into PHA-PBMC. Supernatant p24 antigen was measured as ng/ml. Data are representative of three independent
experiments. (C) HXB2 and HXB2/LW replication in SCID-hu Thy/Liv mice. The replication of HXB2 and HXB2/LW was compared in the SCID-hu
Thy/Liv mouse. Cell-associated p24 antigen was measured as pg/106 thymocytes. Numbers in parentheses indicate number of animals analyzed.
Standard errors are shown. (D) Semiquantitative PCR of infected SCID-hu thymocytes. Human thymocytes from Thy/Liv grafts infected with NL4.3
(NL4), HXB2 (HB), or HXB2/LW (LW) were assayed by semiquantitative DNA PCR. a, b, and c indicate different SCID-hu Thy/Liv mice analyzed.
Lanes 1, 10,000 sample cells; lanes 2, 1000 sample cells plus 9000 normal human cells; lanes 3, 100 sample cells plus 9900 normal human cells.
ACH2 cells (one HIV-1 genome/cell) were used as a standard control. – , no DNA control.
for human cells. Immunohistochemical analysis with Multiple determinants contribute to the enhanced
replication in the Thy/Liv organanti-HIV-1 anti-serum demonstrated HXB2/LW-infec
ted cells with both thymocyte and nonthymocyte mor-
To map molecular determinants associated with repli-phology (data not shown). Similar results were ob-
cation in vivo, recombinants between HXB2 and differenttained after challenge of the TOC model system (Bony-
parts of the LW87-1 region in HXB2/LW were preparedhadi et al., 1995): as measured by viral p24 production,
(Fig. 2A). All of the recombinants showed similar replica-HXB2/LW but not HXB2 showed high levels of replica-
tion (Fig. 2B). tion capacity in PHA-PBMC except LW-H/B, which
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FIG. 2. Mapping of HIV-1 determinants in the LW sequences responsible for replication in vivo. (A) The 2.7-kb (SalI to BamHI) LW87-1 sequences
in HXB2/LW were dissected to generate the following recombinants in the HXB2 genetic background. HXB2/LW, SalI (5786) to BamHI (8466); LW-
S/K, SalI (5786) to KpnI (6348); LW-K/B, KpnI (6348) to BglII (7032); LW-B/N, BglII (7032) to NheI (7257); LW-H/B, HindIII (8132) to BamHI (8466). The
asterisks indicate the nonsense mutations in the HXB2 genome. LW-S/K replaces the C-terminus of vpr without affecting the nonsense mutation
in the vpr gene. The relative replication capacity in vivo (TOC and SCID-hu mice, B and C) of these recombinants is summarized on the right. ///,
replication comparable to primary isolates or NL4.3 (p24 levels ⁄500 pg/106 cells, ⁄10% infection as determined by DNA PCR); //, p24 level
⁄100 pg/106 cells, ⁄1% infection by PCR assay; /, p24 level ⁄10 pg/106 cells, 1% infection by PCR assay; 0, no detectable p24 production, no
infection detected by PCR. (B) Replication of HXB2/LW recombinants in TOC. The TOC model was used to screen the recombinants as an initial
test of their replication potentials in human thymus. p24 assays were performed 7–8 days postinfection. The labels are as in Fig. 1C. (C) Replication
of HXB2/LW recombinants in SCID-hu Thy/Liv mice. HIV-1-infected SCID-hu mice were terminated and analyzed 4–6 weeks postinfection with the
indicated HIV-1 clones. Labels are as described in Fig. 1C.
showed a delayed replication kinetics (data not shown). 1 region, LW-B/N (a 225-bp fragment encoding the V3
loop and some flanking env sequences) showed theThe TOC model was used to facilitate the screening of
these recombinants. As shown before (Fig. 2B and Bony- highest level of replication, whereas LW-K/B (encoding
V1V2C2) and LW-S/K (encoding the first exons of tat andhadi et al., 1995), HXB2 replicated poorly in TOC. HXB2/
LW, on the other hand, replicated efficiently in TOC (Fig. rev, vpu, and the N-terminal 43 amino acids of env)
showed lower, but significant, levels of replication. LW-2B). In SCID-hu Thy/Liv (Figs. 1C and 2C), HXB2 repli-
cated poorly and HXB2/LW replicated to high levels. H/B (encoding the second exon of tat, part of the second
exon of rev, and the transmembrane portion of gp41)Among those recombinants which subdivided the LW87-
AID VY 8338 / 6a22$$$462 12-04-96 10:59:44 vira AP: Virology
49HIV-1 ENV DETERMINANTS FOR IN VIVO REPLICATION
FIG. 3. LW-B/N sequence analysis. (A) DNA sequences and deduced amino acid sequences. Plasmid DNA was used directly for sequencing
with primers based on HXB2 sequences before the BglII site or after the NheI site. (B) Alignment of LW and HXB2 sequences (aa) of the BglII–
NheI fragment. The V3 loop is in bold and the changed residues are underlined. The charged residues are marked with / or 0.
failed to show any significant replication. Notably, HXB2/ tural properties within the envelope protein. The K/ to
E0 change C-terminal to the V3 loop may also result inLW replicated to higher levels than any of these recombi-
nants, suggesting additive or synergistic contributions altered inter- or intramolecular interactions and thereby
be associated with properties of infectivity in vivo. Furtherfrom individual, segregated regions. Figure 2A summa-
rizes data from TOC as well as SCID-hu mice. At the analysis of these changes may help to illuminate their
relative importance to HXB2/LW replication in vivo.resolution of this experiment, however, most of the deter-
minants for HXB2/LW infectivity in vivo were carried in
the V1–V3 region of env, especially in the BglII– NheI (V3 DISCUSSION
loop) fragment.
It has been reported that HIV-1 isolates which grow
out from a given patient in cell culture are not representa-Identification of amino acid residues in the V3 loop
tive of those observed within the same patient in vivoregion which contribute to the enhanced replication
(Meyerhans et al., 1989). In the case of other lentiviruses,in the Thy/Liv organ
single point mutations have been shown to revert an
attenuated to a pathogenic strain in vivo (Kestler et al.,The LW-B/N fragment was sequenced (Fig. 3A). Com-
parison of its deduced amino acid sequences with that 1991). The present study documents the first example of
unique structural determinants in HIV-1 that appear toof HXB2 (Fig. 3B) revealed six amino acid changes
(underlined), three N-terminal to the V3 loop, two in the be necessary for infectivity in vivo, but not in PBMC or
in immortalized T cell lines. Interestingly, the relevantV3 loop, and one immediately C-terminal to the V3 loop.
The two changes in the V3 loop have been maintained changes do not affect the nef gene, previously implicated
for pathogenicity of SIV in rhesus macaques (Kestler etin all viral isolates derived from the lab worker since
1987, 2 years after the accidental infection (Reitz et al., al., 1991) or of HIV-1 in SCID-hu mice (Jamieson et al.,
1994). The vpu and vpr genes, which have also been1994), and one, the A to T change, has been demon-
strated previously to be responsible for resistance to reported to affect HIV-1 replication in SCID-hu Thy/Liv
mice (Aldrovandi and Zack, 1996), of HXB2/LW and theneutralizing antibodies (Di Marzo Veronese et al., 1993;
Reitz et al., 1994). There is otherwise no consistent corre- recombinants also remain defective. Thus, previously un-
described features of the V3 region of env that are neces-lation between the selection for (or against) these partic-
ular amino acid residues among other HIV-1 V3 loop sary for infection of natural target cells are revealed by
phenotypic and molecular analyses of HIV-1 isolates insequences (in relation to transmission or in vitro growth
characteristics) that have been entered in the data base the human organ implants of the SCID-hu mouse. It is
noteworthy that the V3 region of NL4.3 is almost identical(data not shown). If they are critical for infectivity of HXB2/
LW in vivo, their role may be to affect higher order struc- to that of HXB2 (only one A to V change N-terminal to
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the V3 loop). It is likely that the LW env determinants et al., 1993; Aldrovandi and Zack, 1996; Bonyhadi et al.,
1993; Jamieson et al., 1994; Kaneshima et al., 1994; Nami-bind/interact with unique target cells and/or receptors to
enhance viral replication in the human thymus via a NEF- kawa et al., 1988; Stanley et al., 1993; Su et al., 1995). It
is notable that HIV-1 such as HXB2 (derived from Lai/independent mechanism.
Thymocytes are clearly the primary cells infected by IIIB), which had been adapted in immortalized T cells
and which did not grow out efficiently within the infectedHXB2/LW, both by thymocyte-associated p24 assay and
by immunohistochemistry (data not shown). The most lab worker, also did not replicate efficiently in the SCID-
hu Thy/Liv implant. Such impaired growth in the SCID-likely mechanism of enhanced replication by HXB2/LW
is that HXB2/LW infected certain target cells (thymocytes hu Thy/Liv model has been observed with an attenuated
measles virus vaccine strain (Auwaerter et al., 1996) andor macrophages) which sensitized the other thymocytes
for supporting HIV-1 replication. Cytokines which en- with tissue culture-adapted isolates of cytomegalovirus
(Mocarski et al., 1993). This small animal model mayhance HIV-1 replication have been shown to be upregu-
lated in HIV-1-infected Thy/Liv organs (M. Bonyhadi, L. thus be useful in the definition and characterization of
molecular determinants of other pathogenic organismsSu, J. Auten, and H. Kaneshima, unpublished observa-
tions). Identification of those ‘‘initiator cells’’ will be of as well as HIV-1 which, when altered, result in attenuated
growth in vivo.importance to understand the enhanced replication by
HXB2/LW. Alternatively, the LW env region may simply
interact uniquely with the receptors on human thymo- MATERIALS AND METHODS
cytes to enhance the infectivity of HXB2/LW in human
Construction of recombinant HIV-1 genomesthymocytes. Identification of the target cells infected by
HXB2/LW will help to clarify this question. The HXB2 genomic DNA was digested with SalI and
The replication of HXB2 in the Thy/Liv organ at late BamHI to drop out the 2.7-kb fragment and the corre-
time postinfection (8 weeks p.i.; Fig. 1C) may suggest sponding fragment from LW87.1 was ligated into the pro-
that HXB2 can infect target cells in the Thy/Liv organ. virus DNA to generate the HXB2/LW provirus. The muta-
However, it either replicates or transmits very slowly in tions in vpr, vpu, and nef are still present in the genome.
the target cells. It is also possible that HXB2 may have Construction of HXB2/LW recombinant genomes was
acquired mutations which contribute to enhanced repli- carried out by subcloning the indicated fragments in
cation at late times. It will be of interest to analyze the HXB2/LW into HXB2 proviral DNA. The 2.7-kb (SalI to
HIV genome from late time postinfection for possible BamHI) LW87-1 sequences in HXB2/LW were dissected
accumulation of specific mutations (e.g., in nef and/or V3 to generate the following recombinants in the HXB2 ge-
loop regions). netic background. HXB2/LW, SalI (5786) to BamHI (8466);
It is of great interest that the same SalI to BamHI LW-S/K, SalI (5786) to KpnI (6348); LW-K/B, KpnI (6348)
fragment from HXB2 also shows in vivo defects in the to BglII (7032); LW-B/N, BglII (7032) to NheI (7257); LW-
SIV–HIV chimeric (SHIV) genome (Lu et al., 1996; Rei H/B, HindIII (8132) to BamHI (8466). The asterisks (Fig.
mann et al., 1996). In one report, SHIV-HXB2c showed 2A) indicate the nonsense mutations in the HXB2 ge-
greatly reduced replication in infected monkeys com- nome. LW-S/K replaces the C-terminus of vpr without
pared with SHIV-89.7 (a primary HIV-1 isolate), although affecting the nonsense mutation in the vpr gene.
both chimeric viruses replicated efficiently in simian
PBLs in vitro (Reimann et al., 1996). In the second report, HIV-1 replication in PBMC and viral supernatant
the SHIV-HXB2c virus appeared to be defective in estab- production
lishing infection in monkeys after intravaginal inoculation
Equal amounts of proviral DNA (20 mg) were trans-(Lu et al., 1996). Both reports indicate that lab-adapted
fected into PHA-activated PBMC as described (Su et al.,HIV-1 isolates may have accumulated mutations in im-
1995). PHA-activated PBMC (obtained as buffy coats fromportant genes for in vivo replication and transmission.
Stanford Blood Center, CA) were cultured at 106 cells/However, the fragment in the SHIV chimeric viruses en-
ml with IL2 (20 units/ml). Supernatant was collected atcodes HIV-1 vpr, vpu, rev, and tat, as well as env. It
indicated times and stored for p24 assay. TCID50 assayis not clear which gene(s) contributes to the observed
(10-fold dilution) was performed with PHA-PMBC. Thedifferences.
supernatant with TCID50 greater than 4000/ml (p24 levelsThe Thy/Liv organ of the SCID-hu mouse has served
100–200 ng/ml) was stored as viral stock for infection.previously as a useful model for the analysis of normal
thymocyte differentiation (Kraft et al., 1993; Krowka et al., Infection of SCID-hu mice or TOC
1991; McCune et al., 1988; Vandekerckhove et al., 1992;
Waller et al., 1992). As judged by the parameters of viral Animal transplantation procedures for SCID-hu Thy/
Liv construction have been described elsewhere (Nami-replication, tropism, cytopathic effects, and in vivo antivi-
ral effects, it also appears to faithfully reproduce the kawa et al., 1990). Infection of SCID-Thy/Liv mice was
performed as described (Su et al., 1995). Briefly, SCID-expected attributes of HIV-1 infection in vivo (Aldrovandi
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hu Thy/Liv mice (4–6 months after transplantation) were REFERENCES
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Aldrovandi, G. M., and Zack, J. A. (1996). Replication and pathogenicityPBMC containing no HIV-1 (mock) or 4 1 103 to 104
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TCID50/ml of HIV-1. Fifty microliters (200 to 2000 TCID50) 1511.
were injected into each thymus graft. The Thy/Liv organs Aldrovandi, G. M., Feuer, G., Gao, L., Jamieson, B., Kristeva, M., Chen,
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fin, D. E. (1996). Measles virus infection of thymic epithelium in the
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Bonyhadi, M. L., Rabin, L., Salimi, S., Brown, D. A., Kosek, J., McCune,ments under the dissecting scope using sterile tech-
J. M., and Kaneshima, H. (1993). HIV induces thymus depletion inniques. These fragments, usually containing at least one
vivo. Nature 363, 728–732.to two intact thymic lobules, were transferred into sterile
Bonyhadi, M. L., Su, L., Auten, J., McCune, J. M., and Kaneshima, H.
vials containing either control supernatant from mock- (1995). Development of a human thymic organ culture model for the
infected human PHA-PBMC or virus-containing superna- study of HIV pathogenesis. AIDS Res. Hum. Retroviruses 11, 1073–
1080.tant from infected PHA-PBMC. The vials were gently
Chang, S. P., Bowman, B. H., Weiss, J. B., Garcia, R. E., and White, T. J.rocked at room temperature for 2 hr, and then fragments
(1993). The origin of HIV-1 isolate HTLV-IIIB. Nature 363, 466–469.were transferred to 0.45-mm nucleopore filters (Millipore)
Di Marzo Veronese, F., Reitz, M. S., Gupta, G., Robert-Guroff, M., Boyer-
atop gelfoam boats (Upjohn) saturated in media (RPMI, Thompson, C., Louie, A., Gallo, R. C., and Lusso, P. (1993). Loss of
10% fetal calf serum, 50 mg/ml streptomycin, 50 U/ml a neutralizing epitope by a spontaneous point mutation in the V3
loop of HIV-1 isolated from an infected laboratory worker. J. Biol.penicillin G, 11 MEM vitamin solution [GIBCO/BRL], 11
Chem. 268, 25894–25901.insulin/transferrin/sodium selenite media supplement
Fauci, A. S. (1993). Multifactorial nature of human immunodeficiency[Sigma]), in six-well tissue culture plates. The fragments
virus disease: Implications for therapy. Science 262, 1011–1018.
were then cultured at 377, 5% CO2 for 7–8 days with daily Hahn, B. H., Shaw, G. M., Arya, S. K., Popovic, M., Gallo, R. C., and
changes of culture media. Wong, S. F. (1984). Molecular cloning and characterization of the
HTLV-III virus associated with AIDS. Nature 312, 166–169.Measurement of cell-associated p24 production (pg/
Huppes, W., De, G. B., Zurcher, C., and Van, B. D. (1992). Acute human106 thymocytes) was performed using a p24 ELISA kit
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